SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-22-000021
Filing Date
2022-11-09
Accepted
2022-11-09 08:02:00
Documents
95
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q anip-20220930x10q.htm   iXBRL 10-Q 2873929
2 EX-10.1 anip-20220930xex10.htm EX-10 496654
3 EX-31.1 anip-20220930xex31d1.htm EX-31.1 11358
4 EX-31.2 anip-20220930xex31d2.htm EX-31.2 10778
5 EX-32.1 anip-20220930xex32.htm EX-32 8613
6 GRAPHIC anip-20220930xex10004.jpg GRAPHIC 691
7 GRAPHIC anip-20220930xex10001.jpg GRAPHIC 643
8 GRAPHIC anip-20220930xex10002.jpg GRAPHIC 883
9 GRAPHIC anip-20220930xex10007.jpg GRAPHIC 703
  Complete submission text file 0001023024-22-000021.txt   11949956

Data Files

Seq Description Document Type Size
10 EX-101.SCH anip-20220930.xsd EX-101.SCH 61148
11 EX-101.CAL anip-20220930_cal.xml EX-101.CAL 87480
12 EX-101.DEF anip-20220930_def.xml EX-101.DEF 319402
13 EX-101.LAB anip-20220930_lab.xml EX-101.LAB 485220
14 EX-101.PRE anip-20220930_pre.xml EX-101.PRE 503384
89 EXTRACTED XBRL INSTANCE DOCUMENT anip-20220930x10q_htm.xml XML 2340357
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 221370729
SIC: 2834 Pharmaceutical Preparations